| Rose Malfa, MD | |
|
Gaylord Farms Rd., Wallingford, CT 06492 | |
| (203) 284-2800 | |
| (203) 679-3598 |
| Full Name | Rose Malfa |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | Gaylord Farms Rd., Wallingford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275514507 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 025264 (Connecticut) | Primary |
| Entity Name | Gaylord Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730137753 PECOS PAC ID: 1153224191 Enrollment ID: O20040128000878 |
News Archive
Screening families of patients with bowel cancer for a genetic condition would cut their risk of developing bowel, womb, and ovarian cancers, new research has found.
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that the organization's Newborn Screening Pilot has successfully reached its completion, screening more than 36,000 babies born in New York State over the last two years.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX™ is now available in the U.S. by prescription, for the treatment of adult Dupuytren's contracture patients with a palpable cord. Dupuytren's contracture is a debilitating disease resulting from excessive collagen deposition that causes contractures of the fingers.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced the completion of enrollment in a Phase 2a proof-of-concept trial for the treatment of impetigo.
Neurocrine Biosciences, Inc. today announced results from the open-label portion of the six month Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rose Malfa, MD Po Box 400, Gaylord Farms Rd., Wallingford, CT 06492-7048 Ph: (203) 284-2800 | Rose Malfa, MD Gaylord Farms Rd., Wallingford, CT 06492 Ph: (203) 284-2800 |
News Archive
Screening families of patients with bowel cancer for a genetic condition would cut their risk of developing bowel, womb, and ovarian cancers, new research has found.
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that the organization's Newborn Screening Pilot has successfully reached its completion, screening more than 36,000 babies born in New York State over the last two years.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX™ is now available in the U.S. by prescription, for the treatment of adult Dupuytren's contracture patients with a palpable cord. Dupuytren's contracture is a debilitating disease resulting from excessive collagen deposition that causes contractures of the fingers.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced the completion of enrollment in a Phase 2a proof-of-concept trial for the treatment of impetigo.
Neurocrine Biosciences, Inc. today announced results from the open-label portion of the six month Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
› Verified 5 days ago
Anatoly Braylovsky, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 850 N Main Street Ext, Building 2 Suite 1b, Wallingford, CT 06492 Phone: 203-269-4200 Fax: 203-269-8800 | |
Henry Bear Hofbauer, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 850 N Main Street Ext, Building 2, Suite C3, Wallingford, CT 06492 Phone: 203-265-6522 Fax: 203-265-5605 | |
Alla Bernshteyn, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 67 Masonic Ave, 1st Floor, Wallingford, CT 06492 Phone: 203-265-0355 Fax: 203-265-7413 | |
Dr. Richard Alexander Bugliari, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1062 Barnes Rd, Ste 300, Wallingford, CT 06492 Phone: 203-265-9831 Fax: 203-265-2977 | |
Dr. Colleen Sherkow, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 863 N Main Street Ext, Suite 103, Wallingford, CT 06492 Phone: 203-694-5500 Fax: 203-694-5520 | |
Dr. Muhammad K. Al Mounayer, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: Gaylord Hospital, Gaylord Farm Rd., Wallingford, CT 06492 Phone: 203-284-2800 Fax: 203-679-3598 | |
Allison Padegimas, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1062 Barnes Rd Ste 300, Wallingford, CT 06492 Phone: 203-265-9831 |